This application claims priority from United Kingdom Patent Application No. 1416055.0, filed on Sep. 11, 2014, which is incorporated herein by reference in its entirety.
The present invention seeks to improve upon existing methods of portal imaging during radiotherapy treatment.
Radiotherapy is the treatment of lesions such as tumours with ionising radiation such as high-energy x-rays. The radiation interferes with cellular processes within the tumour and can lead to cellular death. To spare healthy tissue (such as skin or organs adjacent to the tumour, or through which the radiation needs to pass in order to treat the tumour), shaped radiation beams are aimed from several different angles to intersect at the tumour, thus delivering a peak dose in the tumour region and a lower dose elsewhere.
To allow delivery of the radiation from several angles, the radiation source is usually mounted on the end of a cantilever arm projecting out from a rotatable gantry. The gantry has an axis of rotation that is horizontal, and the radiation source has a field of view whose central axis is perpendicular to and intersects with the axis of rotation. Thus, the point of intersection or “isocentre” remains within the field of view of the source at all times, and the direction of the radiation beam rotates around the isocentre.
To shape the radiation beam, collimators are provided. These usually include one or more multi-leaf collimators (MLCs), which collimate the radiation field into the required shape by moving each of a number of long, narrow side-by-side leaves so that the tips of the leaves define the intended shape. Prior to radiotherapy, a treatment plan will usually be calculated based on the parameters of the radiotherapy apparatus and the desired three-dimensional dose distribution, which consists of a series of dose segments each characterised by a beam direction, beam shape (i.e. specific collimator positions) and dosage.
Portal images are images of the therapeutic radiation taken after attenuation by the patient, usually by capturing the image in a plate that is located on the opposite side of the patient to the radiation source. Thus, the radiation passes through the patient and then reaches the portal imager. Although the contrast in a portal image is relatively poor due to the nature of the high-energy x-radiation that is used for radiotherapy, the image is still useful. It is possible to discern some features of the patient anatomy in order to determine correct positioning, the overall shape of the radiation field is visible and provides a check of collimator function and field shape & size, and the attenuation (i.e. the difference between the observed radiation intensity after the patient and the known radiation intensity emitted towards the patient) gives information as to the dose actually received by the patient. All of these can be compared to that which was expected during the treatment planning stage.
Portal images were originally captured using port films, i.e. photographic plates. These films would serve as a record of the field shape, and if anatomy could be seen in the field then it could be also used to verify the position of the beam relative to the patient's anatomy. Electronic Portal Imaging Devices (“EPIDs”) have now been in use for some time in preference to port films, as they have better sensitivity than films and allow the images to be collected and stored electronically. An EPID is now a well-established part of radiotherapy delivery.
Because EPIDs are now quite common on modern radiotherapy equipment, a number of uses for EPIDs have been developed that go beyond the original port-film single exposure use. This includes portal dosimetry (noted above) which attempts to recalculate the patient dose by a method such as back projection, in order to check the end to end QA process. Another example is the capturing of video images showing the dynamic movement of the MLC leaves. All these uses are possible with existing EPID hardware.
However, these new uses do have a limitation in that the field size of current EPIDs is smaller than the field sizes of most MLCs. For example, a typical MLC has a 40×40 cm field size when referenced to the isocentre, whereas a typical state-of-the-art EPID has a panel giving an effective image size of 26×26 cm at isocentre, and some EPIDs are smaller still (all dimensions being referenced to the isocentre). This is rarely a problem in obtaining an image of the treatment, however, because large field sizes are uncommon and so will usually fall onto the panel within its limits. Where the desired image is of an offset field, the panel can be manually adjusted to provide a corresponding offset.
US2007/0195936A1 discloses an arrangement in which the field size is checked to ensure that the EPID aperture will not be exceeded, and moves the MLC leaves as necessary in order to keep the beam shape within the confines of the EPID panel.
The present invention therefore provides a radiotherapy apparatus, comprising a source for producing a beam of ionising radiation along an axis, the beam covering a maximum aperture of the source, a collimator for collimating the beam to produce a collimated beam covering a sub-part of the maximum aperture, a patient support positioned in the path of the beam, a rotatable gantry, on which the source is mounted, for rotating the source around the patient support thereby to deliver the beam from a range of directions, an imaging device located opposite the source and with the patient support between the source and the imaging device, and mounted on the gantry via a drive member allowing translational motion of the imaging device in at least one direction perpendicular to the axis, and a control unit adapted to control the drive member to move the imaging device within the maximum aperture and maintain coincidence between the imaging device and the sub-part of the maximum aperture.
Accordingly, the EPID can be moved during the treatment in order to maintain the collimated field of the radiation beam within the bounds of the EPID. This ensures that the image is valid and prevents damage to the EPID as a result of exposure of more sensitive (or less shielded) parts to the beam. No restrictions need be placed on the positioning of the patient, meaning that she or he can be positioned as desired. The treatment can be unaffected, unlike the suggestion made in US2007/0195936A1.
There are various ways that the movement of the EPID can be controlled. One option is for the control unit to receive a treatment plan containing instructions for at least movement of the rotatable gantry, movement of the collimator, activation of the source, and movement of the drive member. In other words, alongside calculations of the necessary beam shapes and intensities over time, a treatment planning computer can also model the beam shape and position through the treatment (once the treatment is decided) and establish the EPID movements that will be needed in order to allow for that.
An alternative is to adjust the EPID position in real time during treatment. The control unit will then receive an output image from the imaging device and adjust the position of the imaging device in reliance on that image. Thus, for example, if a distance in the output image between an image of the collimated beam and an edge of the output image is less than a threshold, the control unit will instruct a movement of the drive member.
The gantry can be a rotatable drum, in which case the source can be attached to the gantry via an arm extending transversely to the drum, preferably with the beam axis co-incident with a rotation axis of the gantry.
Alternatively, the gantry can comprise a circular path around which the source and the imaging device can travel, the axis of the source being directed to the centre of the circular path.
In essence, therefore, the radiotherapy apparatus comprises a source arranged to emit a beam of therapeutic radiation and an imaging device for the therapeutic radiation, the source being movable to direct the beam towards a location from a plurality of directions and the imaging device being movable relative to the source, and a control unit arranged to co-ordinate the movement of both to ensure that the imaging device remains in the beam, as the source moves to different treatment positions.
An embodiment of the present invention will now be described by way of example, with reference to the accompanying figures in which;
As noted above, the field size of current EPIDs is smaller than the maximum apertures of most MLCs, although larger than most actual dose shapes. We have realised that this limitation becomes a problem when the EPID is used for portal dosimetry or to capture a dynamic MLC video under certain treatment conditions. As an example, we propose to discuss a volumetric modulated arc therapy (VMAT) delivery to an off-axis target such as a tumour present in one breast or lung. This is not the only example, however, and the invention is applicable in other contexts.
The tumour 16 is positioned relative to the beam by placing the patient 18 on a patient support 20. This is separate to the gantry, usually supported on a floor in front of the gantry. Many modern patient supports offer adjustment in six axes, i.e. three translational axes and three rotational axes. In this way, after the patient 18 has been helped onto the support, their position can be adjusted via the patient support 20 so as to locate the tumour as desired. Some limits will of course be imposed by the range of motion of the patient support 20.
An EPID 22 is also carried by the gantry 10, located diametrically opposite the radiation source 12 to as to capture an image from the radiation beam after attenuation by the patient 18, as described above. As the gantry rotates, this will rotate with the gantry so as to maintain its position relative to the radiation source 12. The EPID could alternatively be carried by a separate structure, arranged to support the EPID in a suitable location opposite the source, but mounting it on the same gantry is likely to be easier and more accurate.
However, as the gantry rotates (
Thus, although the actual field size (projected to isocentre) is likely to be smaller than the 26×26 cm aperture of the EPID 22, the offset position of beam may track across the full 40×40 cm beam aperture of the collimator as the gantry rotates. Thus, if the EPID is being used to collect portal dosimetry data, then some data will be lost and this will compromise the ability to accurately calculate the portal dose, as well as potentially causing damage to the EPID.
So, the treatment can be planned with the tumour placed away from the isocentre on the machine, to allow the patient to be positioned centrally, avoid collision risk, and allow use of the full 360° rotation of the source, but the EPID will not be available. Alternatively, the tumour can be positioned centrally, but the full range of rotation may not be available, so the treatment may be sub-optimal. In a further alternative, according to US2007/0195936A1, the MLC leaf positions are adjusted to ensure that the EPID is protected and usable, but this will also affect the treatment and render it sub-optimal.
An apparatus of this type presents additional difficulties, in that where the target is offset it will not generally be possible to offset the patient as shown in
Both problems can be addressed using the apparatus of
A radiotherapeutic source 110 is mounted on the drum, offset from its front face 112 by a gantry arm 114. The source 110 is aimed towards the rotation axis 106, thus defining an isocentre where the rotation axis 106 meets the central axis of the beam emitted by the source 110. A collimator arrangement 116 is included in the radiation source 110 so as to shape the beam as desired and allow the required dose distribution to be built up.
An EPID 118 is also mounted on the gantry 104, via a gantry arm 120 that extends transversely from the front face 112 of the gantry 104 so as to place the EPID 118 generally opposite the source 110, with the patient 100 and the patient support 102 between them. This allows the EPID 118 to capture an image of the beam as attenuated by the patient 100. The EPID 118 is connected to its gantry arm 120 via a series of servo-controlled linkages 122 that allow x-y movement of the EPID 118 relative to the gantry arm 120. The two translation axes of the linkages 122 are arranged transverse to the beam direction, so the effect of translating the EPID 118 is to scan it across the field of the beam. The gantry arm 120 and/or the linkages 122 may be also able to move the EPID 118 in a z-direction, i.e. towards or away from the source 110. However, for the purposes of the present invention we are principally concerned with movement in the x and y directions; motion in the z direction is in principle irrelevant to the invention apart from its influence on the effective image size within the beam aperture.
The movement of the EPID 118 in the y direction (i.e. parallel to the rotation axis 106) will usually be in a straight line. Its movement in the x direction (i.e. perpendicular to both the rotation axis 106 and the beam axis, into and out of the page in
In practice, the apparatus control unit 132 may comprise several sub-modules, each attending to different functional aspects of the apparatus, which may be distributed around the apparatus as required.
Also shown in
A first way is to predict the necessary EPID movements and adjust it accordingly. Accordingly, the treatment planning computer 128 can use its a priori knowledge of the collimator positions during the treatment to calculate the required position of the EPID 118 at each point during the treatment. This can be done using simple ray projection methods, either to determine where the beam will fall in the plane containing the EPID, or to determine a correlation between EPID positions and MLC leaves and positions, from either of which the necessary EPID position for each collimator shape during the treatment can be determined. If a collimator shape is called for during treatment that is so large or unusual that the EPID cannot accommodate it, then the system can either issue a warning to the clinician or can incorporate the EPID size as an apparatus limitation within document 126 and then calculate or re-calculate the treatment plan, as necessary. The EPID positions during treatment that are determined in this way can then be incorporated into the treatment plan 130 and passed to the apparatus control unit 132. During the treatment, the apparatus control unit 132 can then control the EPID drive motors 140 as required in order to achieve this. Adjustments to the planned EPID positions may of course be needed in view of any adjustments made to the planned collimator positions, such as to compensate for movement of the target.
Of course, the EPID position calculations could be done by a separate module within the treatment planning computer 128, or by a different computing element, or by the apparatus control unit 132. In the latter case, the necessary EPID positions could be calculated in real time while acting on the collimator positions contained in the treatment plan.
The alternative control mechanism for the EPID drive motors is a reactive feedback method which uses the images obtained from the EPID in order to determine a necessary movement. This is shown in
As the treatment progresses, with rotation of the gantry and adjustment of the collimator shape, the beam shape 152 may well move as shown in
As illustrated in
In either case, the EPID position is ideally recorded during the treatment, such as in conjunction with the images obtained from it. This then allows the images to be corrected for the EPID offset. Alternatively, the images could be processed in real time by offsetting them against (say) a plain background by an amount corresponding to the EPID offset when they were captured. The saved set of images are then in a comparable format for later analysis.
Accordingly, the present invention allows the EPID to be used for real-time diagnostic purposes, regardless of the type of treatment, and without having to make potentially detrimental adjustments to the treatment plan. It will of course be understood that many variations may be made to the above-described embodiment without departing from the scope of the present invention.
Number | Date | Country | Kind |
---|---|---|---|
1416055 | Sep 2014 | GB | national |
Number | Name | Date | Kind |
---|---|---|---|
6345114 | Mackie | Feb 2002 | B1 |
20030086526 | Clark et al. | May 2003 | A1 |
20070195936 | Manthey et al. | Aug 2007 | A1 |
Number | Date | Country |
---|---|---|
203694429 | Jul 2014 | CN |
1308185 | Jul 2003 | EP |
2011189016 | Sep 2011 | JP |
WO 2004105574 | Sep 2004 | WO |
Entry |
---|
UK Intellectual Property Office Search Report dated Mar. 3, 2015 (2 pages). |
Number | Date | Country | |
---|---|---|---|
20160074673 A1 | Mar 2016 | US |